Page last updated: 2024-09-03

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and prostaglandin h2

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with prostaglandin h2 in 1 studies

Compound Research Comparison

Studies
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Trials
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Recent Studies (post-2010)
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Studies
(prostaglandin h2)
Trials
(prostaglandin h2)
Recent Studies (post-2010) (prostaglandin h2)
3611413034

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aksoy, MO; Harakal, C; Smith, JB; Stewart, GJ; Zerweck, CR1

Other Studies

1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and prostaglandin h2

ArticleYear
Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation.
    British journal of pharmacology, 1990, Volume: 99, Issue:3

    Topics: Animals; Bradykinin; Bridged Bicyclo Compounds, Heterocyclic; Dogs; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandin-Endoperoxide Synthases; Prostaglandins H; Pyridines; Receptors, Prostaglandin; Sulfonamides; Thromboxane-A Synthase; Thromboxanes; Veins

1990